Skip to main content
. 2020 Sep 9;10:1710. doi: 10.3389/fonc.2020.01710

Figure 5.

Figure 5

Construction and validation of MRGs signature in melanoma. (A–D) Kaplan-Meier analysis for OS based on the MRGs signature of melanoma patients in TCGA training cohort (A) and GEO validation dataset (C). The distribution of risk score, survival status and expression heatmap of the two MRGs in TCGA training cohort (B) and GEO validation dataset (D). (E,F) Cox regression analysis of MRGs signature and clinicopathological risk factors in TCGA training cohort (E) and GEO validation dataset (F).